Ben Wolfson

I’m a postdoctoral fellow in cancer immunotherapy where I’m focused on rapidly bringing combination therapies to the clinic and identifying novel off-label use cases for standard-of-care therapies and identifying new treatment strategies for underserved patient populations.

I’m also passionate about the intersection between science/technology and society, policy and the future, and enjoy exploring these fields through my own personal research and writing. I also apply these interests through serving as the Editor-inChief/blog-manager for the blog Science Policy for All and as an Associate Editor at the Journal of Science Policy and Governance, where I enjoy helping other early-career writers craft well written news and policy articles.

 

 

______________________________________________________________________________

 

 

Recent Posts

  • Science Policy Around the Web June 16th, 2020
    Originally published at sciencepolicyforall.wordpress.com Big tech companies back away from selling facial recognition to police. That’s progress. In the past two weeks, technology companies IBM and Microsoft have announced that they would no longer sell facial recognition technology, and Amazon implemented a one-year moratorium of their own facial recognition software. These policy changes come in […]
  • Science Policy Around the Web April 21st, 2020
    Originally published at sciencepolicyforall.wordpress.com EPA can’t bar grantees from sitting on science advisory panels, judge rules In February of this year, Judge Denise Cote for the U.S. District Court for the Southern District of New York ruled against the Environmental Protection Agency (EPA) in a suit brought by the Natural Resource Defense Council (NRDC) contesting […]
  • Science Policy Around the Web March 12th, 2020
    Originally published sciencepolicyforall.wordpress.com Fired cancer scientist says ‘good people are being crushed’ by overzealous probes into possible Chinese ties Recent months have seen major developments in the FBI and NIH’s investigation into ties between U.S. research labs and China, with the highest profile case to date alleging that the head of the Harvard Chemistry Department […]
  • Science Policy Around the Web January 7th, 2020
    Originally published at sciencepolicyforall.wordpress.com What CRISPR-Baby Prison Sentences Mean for Research Chinese scientist He Jiankui came to prominence last year after claiming he had used CRISPR/Cas9 to genetically edit human embryos to confer resistance to HIV-1. Twin girls with the mutation were born in October of 2018, and He’s work was confirmed by Chinese investigators […]
  • Science Policy Around the Web October 18th, 2019
    Originally published at sciencepolicyforall.wordpress.com Scientific integrity bill advances in U.S. house with bipartisan support On Thursday the U.S. House of Representatives Science Committee voted to advance scientific integrity bill H.R. 1709 to the house floor by a vote of 25 to six. H.R. 1709 would require federal research agencies to develop their own clear principles […]